Logo image of HPQ.CA

HPQ SILICON INC (HPQ.CA) Stock Fundamental Analysis

TSX-V:HPQ - TSX Venture Exchange - CA40444L1031 - Common Stock - Currency: CAD

0.235  -0.01 (-2.08%)

Fundamental Rating

0

Taking everything into account, HPQ scores 0 out of 10 in our fundamental rating. HPQ was compared to 32 industry peers in the Chemicals industry. HPQ may be in some trouble as it scores bad on both profitability and health. HPQ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

HPQ had negative earnings in the past year.
In the past year HPQ has reported a negative cash flow from operations.
In the past 5 years HPQ always reported negative net income.
In the past 5 years HPQ always reported negative operating cash flow.
HPQ.CA Yearly Net Income VS EBIT VS OCF VS FCFHPQ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

HPQ has a worse Return On Assets (-161.16%) than 89.66% of its industry peers.
Industry RankSector Rank
ROA -161.16%
ROE N/A
ROIC N/A
ROA(3y)-84.58%
ROA(5y)-54.19%
ROE(3y)-470.85%
ROE(5y)-288.01%
ROIC(3y)N/A
ROIC(5y)N/A
HPQ.CA Yearly ROA, ROE, ROICHPQ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600 -800 -1K

1.3 Margins

HPQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HPQ.CA Yearly Profit, Operating, Gross MarginsHPQ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

2. Health

2.1 Basic Checks

HPQ has more shares outstanding than it did 1 year ago.
HPQ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HPQ is higher compared to a year ago.
HPQ.CA Yearly Shares OutstandingHPQ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
HPQ.CA Yearly Total Debt VS Total AssetsHPQ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -8.64, we must say that HPQ is in the distress zone and has some risk of bankruptcy.
HPQ has a worse Altman-Z score (-8.64) than 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.64
ROIC/WACCN/A
WACCN/A
HPQ.CA Yearly LT Debt VS Equity VS FCFHPQ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.44 indicates that HPQ may have some problems paying its short term obligations.
HPQ has a Current ratio (0.44) which is in line with its industry peers.
A Quick Ratio of 0.44 indicates that HPQ may have some problems paying its short term obligations.
HPQ's Quick ratio of 0.44 is in line compared to the rest of the industry. HPQ outperforms 41.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
HPQ.CA Yearly Current Assets VS Current LiabilitesHPQ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

HPQ shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.50%.
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HPQ.CA Yearly Revenue VS EstimatesHPQ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
HPQ.CA Yearly EPS VS EstimatesHPQ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

HPQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HPQ.CA Price Earnings VS Forward Price EarningsHPQ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HPQ.CA Per share dataHPQ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HPQ!.
Industry RankSector Rank
Dividend Yield N/A

HPQ SILICON INC

TSX-V:HPQ (2/21/2025, 7:00:00 PM)

0.235

-0.01 (-2.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap88.74M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -161.16%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-84.58%
ROA(5y)-54.19%
ROE(3y)-470.85%
ROE(5y)-288.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.84%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -8.64
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)620.02%
Cap/Depr(5y)13639.9%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.7%
OCF growth 3YN/A
OCF growth 5YN/A